Projects

Using Narrative medicine to reveal the ‘hidden voice’ of children being treated for advanced chronic kidney disease

Project Description

Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.

Project Duration

2023 - 2024

Project Lead

Dr. Priya Pais

Authors

Dr. Priya Pais, Dr Manjulika Vaz, Elizabeth K Sanson

Project Status

completed

Project Type

St John’s Institutional Ethics Committee (IRB) Grant